Sealonix

About:

Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials.

Top Investors: J2 Ventures, AMED Ventures, Excelestar Ventures, Sparta Group, TiE-Boston

Description:

Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch is intended to bioabsorb within one week of implantation.

Total Funding Amount:

$20M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bedford, Massachusetts, United States

Founded Date:

2023-01-01

Founders:

Amar Sawhney

Number of Employees:

11-50

Last Funding Date:

2023-05-12

IPO Status:

Private

Industries: